News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
445,509 Results
Type
Article (31516)
Company Profile (118)
Press Release (413867)
Multimedia
Podcasts (97)
Webinars (14)
Section
Business (127165)
Career Advice (650)
Deals (18203)
Drug Delivery (122)
Drug Development (57574)
Employer Resources (58)
FDA (12434)
Job Trends (8606)
News (201379)
Policy (18547)
Tag
2025 Best Places to Work (6)
2026 Best Places to Work (8)
2027 BioCapital Standard (2)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
40 Under 40 (3)
Academia (2126)
Academic (1)
Accelerated approval (64)
ADA (30)
Adcomms (25)
Allergies (151)
Alliances (31974)
ALS (232)
Alzheimer's disease (1409)
Antibody-drug conjugate (ADC) (679)
Approvals (13039)
Artificial intelligence (710)
ASCO (299)
Autoimmune disease (477)
Automation (72)
Bankruptcy (120)
Belgium (33)
Best Places to Work (7579)
BIO (49)
Biologics (91)
BIOSECURE Act (9)
Biosimilars (193)
BioSpace Insights (104)
Biotechnology (93)
Bispecific (60)
Bladder cancer (214)
Brain cancer (84)
Breast cancer (766)
Cancer (6895)
Cardiovascular disease (368)
Career advice (563)
Career pathing (27)
CAR-T (455)
CDC (32)
CDMO (148)
Celiac Disease (5)
Cell-line development (2)
Cell therapy (1248)
Cervical cancer (50)
Clinical research (51124)
Collaboration (2036)
Commercialization (58)
Company closure (6)
Compensation (680)
Complete response letters (63)
COVID-19 (1937)
CRISPR (136)
CRO (6)
C-suite (1030)
Cystic fibrosis (123)
Data (8673)
Decentralized trials (4)
Denatured (25)
Depression (123)
Dermatology (144)
Diabetes (563)
Diagnostics (5002)
Digital health (59)
Diversity (5)
Diversity, equity & inclusion (18)
Drug discovery (333)
Drug pricing (111)
Drug shortages (13)
Duchenne muscular dystrophy (262)
Earnings (50146)
Editorial (42)
Employer branding (4)
Employer resources (58)
ESMO (389)
Events (65562)
Executive appointments (771)
Eye disease (18)
FDA (16467)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (3)
Friedreich's ataxia (21)
Frontotemporal dementia (23)
Funding (1536)
Gene editing (269)
Generative AI (56)
Gene therapy (819)
GLP-1 (575)
Government (2960)
Grass and pollen (2)
Guidances (438)
Healthcare (12802)
Hematology (207)
HIV (85)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (10)
IgA nephropathy (128)
Immunology and inflammation (261)
Immuno-oncology (149)
Indications (235)
Infectious disease (2219)
Inflammatory bowel disease (181)
Inflation Reduction Act (12)
Influenza (98)
Intellectual property (268)
Interviews (96)
IPO (8687)
IRA (25)
Job creations (1295)
Job search strategy (463)
JPM (44)
Kidney cancer (31)
Kidney disease (132)
Labor market (28)
Layoffs (306)
Leadership (24)
Legal (2848)
Licensing (84)
Liver cancer (100)
Longevity (44)
Lung cancer (1073)
Lung diease (17)
Lymphoma (561)
Machine learning (59)
Management (24)
Manufacturing (1098)
Marketing (32)
MASH (143)
Medical affairs (3)
Medical device (10778)
Medtech (11036)
Melanoma (164)
Mergers & acquisitions (10487)
Metabolic disorders (1119)
Middle East (2)
mRNA (231)
Multiple sclerosis (224)
Multispecific (5)
NASH (9)
Netherlands (26)
Neurodegenerative disease (414)
Neuropsychiatric disorders (70)
Neuroscience (2924)
Neurotech (2)
NextGen: Class of 2026 (3868)
Non-profit (2432)
Now hiring (37)
Obesity (404)
Opinion (228)
Ovarian cancer (260)
Pain (234)
Pancreatic cancer (359)
Parkinson's disease (342)
Partnered (28)
Patents (566)
Patient advocacy (6)
Patient recruitment (761)
Patient selection (97)
Peanut (62)
People (32971)
Peptides (29)
Pharmaceutical (18)
Pharmacy benefit managers (23)
Phase 1 (17584)
Phase 2 (22698)
Phase 3 (16182)
Pipeline (11228)
Policy (207)
Postmarket research (1384)
Preclinical (7820)
Press Release (61)
Prostate cancer (304)
Psychedelics (51)
Radioligand (2)
Radiopharmaceuticals (292)
Rare diseases (1085)
Real estate (2768)
Recruiting (24)
Regenerative medicine (33)
Regulatory (18190)
Reports (35)
Research institute (1996)
Resumes & cover letters (110)
Rett syndrome (47)
RNA editing (25)
RSV (73)
Saudi Arabia (1)
Schizophrenia (130)
Series A (252)
Series B (179)
Series C (1)
Service/supplier (4)
Sickle cell disease (153)
Special edition (12)
Spinal muscular atrophy (139)
Sponsored (45)
Startups (2184)
State (1)
Stem cells (8)
Stomach cancer (19)
Substance use disorders (7)
Supply chain (95)
Switzerland (17)
Tariffs (35)
Tax incentives (1)
The Weekly (70)
Vaccines (860)
Venture capital (95)
Weight loss (222)
Wet AMD (5)
Women's health (109)
Worklife (4)
Date
Today (91)
Last 7 days (571)
Last 30 days (2658)
Last 365 days (21681)
2026 (19823)
2025 (20591)
2024 (24020)
2023 (27507)
2022 (35246)
2021 (37219)
2020 (35278)
2019 (28555)
2018 (21504)
2017 (20568)
2016 (19052)
2015 (22578)
2014 (16276)
2013 (13570)
2012 (14722)
2011 (15062)
2010 (13173)
Location
Africa (382)
Alabama (50)
Alaska (6)
Arizona (314)
Arkansas (13)
Asia (27159)
Australia (4652)
California (11017)
Canada (2569)
China (1509)
Colorado (460)
Connecticut (443)
Delaware (395)
Europe (60201)
Florida (1837)
Georgia (295)
Hawaii (3)
Idaho (42)
Illinois (912)
India (88)
Indiana (512)
Iowa (26)
Japan (585)
Kansas (66)
Kentucky (41)
Louisiana (36)
Maine (83)
Maryland (1304)
Massachusetts (8199)
Michigan (299)
Minnesota (637)
Mississippi (4)
Missouri (130)
Montana (30)
Nebraska (19)
Nevada (167)
New Hampshire (64)
New Jersey (3066)
New Mexico (27)
New York (3139)
North Carolina (1180)
North Dakota (14)
Northern California (5660)
Ohio (359)
Oklahoma (23)
Oregon (27)
Pennsylvania (2120)
Puerto Rico (16)
Rhode Island (50)
South America (535)
South Carolina (59)
South Dakota (2)
Southern California (4422)
Tennessee (165)
Texas (2140)
United States (39766)
Utah (306)
Vermont (2)
Virginia (232)
Washington D.C. (34)
Washington State (941)
West Virginia (2)
Wisconsin (126)
Wyoming (3)
445,509 Results for "cell guidance systems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance System
November 9, 2026
·
2 min read
Earnings
Alnylam bulls and bears fight it out after business-shaking guidance cut
While Alnylam’s recent reduced revenue guidance spooked investors, analysts remain broadly bullish on the biotech’s commercial prospects.
October 14, 2026
·
4 min read
·
Nick Paul Taylor
IN PARTNERSHIP WITH ROSE BIOSOLUTIONS
Webinar: Optimizing Cell Therapy Manufacturing Efficiency with Cryopreserved Cells
In this webinar, we will show how delayed isolation and cryopreservation of immune cells from fresh leukopaks can drastically impact their stability and functionality. We will also explore how purified and cryopreserved cell populations such as PBMCs and isolated T cells streamline logistics, reduce variability, and enhance transduction efficiency in CAR-T production.
November 12, 2026
·
1 min read
·
BioSpace Insights
FDA
New FDA draft guidance doubles down on expediting approvals of personalized gene therapies
The FDA has outlined a process for allowing a single application to cover multiple variants of a gene therapy. At the same time, the Centers for Medicare & Medicaid Services has revealed plans to expand the Cell and Gene Therapy Access Model to increase patient access to these products.
October 28, 2026
·
4 min read
·
Heather McKenzie
FDA
Atara, Pierre Fabre resubmit twice-rebuffed cell therapy after FDA flips again
Ebvallo, which Pierre Fabre Pharmaceuticals and Atara Biotherapeutics are proposing to treat a posttransplant complication, joins a wave of rejected or discouraged therapies on which the FDA has reversed previous guidance after the exit of former Commissioner Marty Makary.
September 30, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Upgrade of revenue and operating profit guidance
October 5, 2026
·
1 min read
Press Releases
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
June 3, 2026
·
4 min read
Manufacturing
BMS ends Cellares pact over cell therapy production problems, triggering layoffs
Setbacks to efforts to use Cellares’ automated platform to make an approved CAR-T cell therapy led BMS to terminate its partnership with the manufacturing specialist.
August 26, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan
August 3, 2026
·
23 min read
Press Releases
OmniAb Raises 2026 Financial Guidance
August 17, 2026
·
5 min read
1 of 44,551
Next